Is JVSAR or MRK a better dividend investment in 2026?

JVSAR currently yields 229.89% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: JVSAR offers higher current income.

What is the dividend yield difference between JVSAR and MRK?

JVSAR has a forward dividend yield of 229.89% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 226.64 percentage points.

Home › Compare › JVSAR vs MRK

JVSAR vs MRK: Dividend Comparison 2026

JVSAR yields 229.89% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 JVSAR wins by $273.53M in total portfolio value

INVESTMENT

TIME HORIZON10 years

JVSAR

● Live price

229.89%

Share price

$0.87

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$273.56M

Annual income

$147,417,011.12

Full JVSAR calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — JVSAR vs MRK

📍 JVSAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	JVSAR	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, JVSAR + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

JVSAR pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JVSAR

Annual income on $10K today (after 15% tax)

$19,540.23/yr

After 10yr DRIP, annual income (after tax)

$125,304,459.45/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, JVSAR beats the other by $125,303,651.71/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JVSAR + MRK for your $10,000?

JVSAR: 50%MRK: 50%

100% MRK50/50100% JVSAR

Portfolio after 10yr

$136.80M

Annual income

$73,708,980.71/yr

Blended yield

53.88%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JVSAR

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JVSAR buys

MRK buys

No recent congressional trades found for JVSAR or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricJVSARMRK

Forward yield	229.89% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$273.56M ✓	$30.7K
Annual income after 10y	$147,417,011.12 ✓	$950.29
Total dividends collected	$259.68M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: JVSAR vs MRK ($10,000, DRIP)

Year	JVSAR Portfolio	JVSAR Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$33,689	$22,988.51	$11,192	$351.54	+$22.5K → JVSAR
2	$108,425	$72,378.36	$12,524	$392.70	+$95.9K → JVSAR
3	$333,722	$217,707.23	$14,015	$438.65	+$319.7K → JVSAR
4	$983,328	$626,245.04	$15,682	$489.96	+$967.6K → JVSAR
5	$2,776,703	$1,724,542.37	$17,547	$547.23	+$2.76M → JVSAR
6	$7,522,223	$4,551,151.29	$19,632	$611.16	+$7.50M → JVSAR
7	$19,571,480	$11,522,701.34	$21,963	$682.53	+$19.55M → JVSAR
8	$48,960,184	$28,018,699.69	$24,571	$762.18	+$48.94M → JVSAR
9	$117,893,771	$65,506,373.98	$27,486	$851.08	+$117.87M → JVSAR
10	$273,563,346	$147,417,011.12	$30,745	$950.29	+$273.53M → JVSAR

JVSAR vs MRK: Complete Analysis 2026

JVSAR — Stock

JVSPAC Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire businesses in the lifestyle sector and technology. The company was incorporated in 2021 and is based in Wan Chai, Hong Kong. JVSPAC Acquisition Corp. operates as a subsidiary of Winky Investments Limited.

Full JVSAR Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this JVSAR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JVSAR vs SCHD JVSAR vs JEPI JVSAR vs O JVSAR vs KO JVSAR vs MAIN JVSAR vs JNJ JVSAR vs ABBV JVSAR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.